HOME >> MEDICINE >> NEWS
MSG-2 will advance long-term monitoring of Earth's energy balance

This week's launch of MSG-2 will ensure that satellite images continue to be available to European weather forecasters well into the next decade. It also marks a new chapter in a long-term space experiment measuring the available energy that drives the weather as a whole, and helping to establish how much the Earth is heating up.

MSG-2's main instrument is the Spinning Enhanced Visible and Infra-red Imager (SEVIRI) which returns detailed 12-wavelength images of the Earth and its atmosphere every 15 minutes, for use in operational meteorology. As in the case of the original MSG-1 - launched into geostationary orbit back in August 2002 - the drum-shaped satellite also carries a smaller scientific instrument called the Geostationary Earth Radiation Budget (GERB), designed to measure the net balance between incoming radiation from the Sun, and outgoing radiation from the Earth, known as the 'Earth Radiation Budget' which is the energy source for the planet's atmospheric system and the ultimate driver of weather phenomena and climate.

Results from MSG-1's original GERB are being used to enhance scientific understanding of climate processes, how human activities are modifying the climate balance and as inputs to improve the accuracy of complex numerical models. GERB results are also being combined with high-resolution SEVIRI imagery to see how hour-by-hour variations in clouds affect the radiation balance.

"Already GERB data from the first instrument are being used, for example, to study how the daily variation of tropical clouds over Africa affect the climate balance, and also how the huge dust storms that sweep from the Sahara out over the Atlantic can affect the weather and the climate," says Prof. John Harries of Imperial College, Principal Investigator for GERB.

"New aspects of these processes are being observed, with studies carried out by members of the GERB International Science Team (GIST), which includes scientists from t
'"/>

Contact: Mariangela D'Acunto
mariangela.dacunto@esa.int
39-06-941-80-856
European Space Agency
20-Dec-2005


Page: 1 2 3 4

Related medicine news :

1. MSG-2 in position for tonights launch
2. Survival differences by race most apparent in advanced stages of breast cancer
3. New drug shows promise in treatment of advanced thyroid cancer
4. Study finds difference in survival rates among white and black women with advanced breast cancer
5. Antidepressant does not improve symptoms in advanced cancer patients without major depression
6. GSKs Pazopanib shows positive results in patients with advanced renal cell carcinoma
7. GSKs Pazopanib shows positive results in patients with advanced RCC and ovarian cancer
8. VEGF Trap shows activity in patients with advanced ovarian cancer
9. Doctors conclude temsirolimus is effective new treatment for advanced renal cell carcinoma
10. Endoscopic procedures advance physician knowledge and patient care
11. Brain research poised to dramatically advance global society

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/26/2017)... ... April 26, 2017 , ... ... management in hospitals, today announced it has completed a round of funding to ... LLC and its partners. Black Granite Capital is a growth equity firm focused ...
(Date:4/26/2017)... ... ... Journal of Oral Implantology – Tooth loss is not simply an ... complications with speech, eating, and overcompensation of mouth due to the deficiency. To combat ... number of tooth replacements increase, it is imperative to design an implant that will ...
(Date:4/26/2017)... ... April 26, 2017 , ... CareSet ... adoption of e-prescribing as measured in Part D Medicare data. The dataset, called ... pharmacies, either using e-prescribing, faxes or paper. The PaPR (pronounced "paper") data ...
(Date:4/26/2017)... ... April 26, 2017 , ... Elisabete Miranda, ... been honored by Enterprising Women magazine as one of its 2017 Enterprising Women ... business owners. Winners have demonstrated that they have fast-growth businesses, mentor or actively ...
(Date:4/26/2017)... ... April 26, 2017 , ... Infertility may be a result ... has helped many women become pregnant upon treating their diagnosis. , ... outpatient evaluations. We can provide the necessary information to diagnose and treat ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology:
Cached News: